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Abstract
Transcriptional regulation in human cells is a complex process involving a multitude of regulatory elements encoded by the
genome. Recent studies have shown that distinct chromatin signatures mark a variety of functional genomic elements and
that subtle variations of these signatures mark elements with different functions. To identify novel chromatin signatures in
the human genome, we apply a de novo pattern-finding algorithm to genome-wide maps of histone modifications. We
recover previously known chromatin signatures associated with promoters and enhancers. We also observe several
chromatin signatures with strong enrichment of H3K36me3 marking exons. Closer examination reveals that H3K36me3 is
found on well-positioned nucleosomes at exon 59 ends, and that this modification is a global mark of exon expression that
also correlates with alternative splicing. Additionally, we observe strong enrichment of H2BK5me1 and H4K20me1 at highly
expressed exons near the 59 end, in contrast to the opposite distribution of H3K36me3-marked exons. Finally, we also
recover frequently occurring chromatin signatures displaying enrichment of repressive histone modifications. These
signatures mark distinct repeat sequences and are associated with distinct modes of gene repression. Together, these
results highlight the rich information embedded in the human epigenome and underscore its value in studying gene
regulation.
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Introduction
The genome sequence is a static entity defining the possible
transcriptional output of every cell type in the human body [1]. By
contrast, chromatin structure dynamically influences the tran-
scriptional potential of each genomic loci in a particular cell. Over
100 different histone modifications are known to exist, and a single
nucleosome can contain many modifications [2]. However, while
the number of possible combinations of histone modifications far
exceeds the number of nucleosomes in the human body, to date
only a small number of histone modification patterns have been
discovered [2].
Several classes of regulatory elements are marked by different
chromatin signatures [3–5]. Notably, Heintzman et al recently
observed distinct and predictive chromatin signatures at active
promoters and enhancers [6,7]. Numerous studies have also
observed that slight variations in chromatin signatures can
distinguish different states of the same regulatory element [3,5].
For example, active promoters are generally marked by
H3K4me3, repressed promoters by H3K27me3, and poised
promoters by both marks [3]. Similarly, different chromatin
signatures mark enhancers bound by different classes of
transcription factors and co-activators [5]. In more recent
studies, several chromatin signatures were also found at
promoters [4], enhancers [4], and even exons [8–11] using
genome-wide chromatin maps.
These observations prompted us to systematically examine the
chromatin signatures that exist in known and putative regulatory
elements in the human genome. Our goal is to explore whether
other frequently occurring chromatin signatures exist, and
whether specific functions are associated with these signatures.
Focusing on 21 histone modifications mapped in CD4+ T cells
[12], we find only a handful of distinct chromatin signatures at
promoters, and that they correlate with gene expression. We then
examine signatures spanning almost 50,000 regions in the human
genome that are distal to previously annotated regulatory sites. We
recover 7 distinct chromatin signatures, some containing enrich-
ment of H3K36me3 that has been recently linked to marking
exons [8]. Upon further inspection, we observe that H3K36me3 is
most strongly enriched at a well-positioned nucleosomes located at
the 59 ends of exons. We also find that stronger enrichment of
H3K36me3 correlates with increased exon usage in alternatively
spliced genes. Finally, we recover two distinct chromatin
signatures rich in repressive histone modifications marking distinct
regions of the genome, that are associated with different modes of
gene repression.
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Chromatin signatures distinguish different classes of
expressed promoters
We hypothesize that loci sharing common regulatory functions
may share similar chromatin signatures. To systematically identify
chromatin signatures genome-wide, we examine different classes of
regulatory loci in turn. These loci may contain chromatin
signatures, but they may not be aligned or even oriented in the
same direction. We therefore apply an unbiased clustering and
alignment method called ChromaSig [5] (see Methods) to find
over-represented chromatin modification patterns spanning these
loci while simultaneously aligning and orienting their enrichment
profiles, focusing on histone modification maps profiled recently in
CD4+ T cells [12]. As a proof of principle that this approach yields
biologically significant results, we first studied promoters.
While chromatin signatures at promoters have been studied
extensively, we still do not have a complete picture of all the
distinct, commonly occurring chromatin signatures spanning all
promoters. As such, our understanding of how different signatures
relate to gene expression is incomplete. To address this, we apply
ChromaSig to the chromatin modifications near the set of
manually annotated promoters defined in the Refseq database
[13]. We recover 14 clusters spanning 18,533 promoters (Fig. 1,
Table 1, Table S1). Promoters in the same cluster share a
common chromatin signature, and the chromatin signatures of
different clusters are distinct in apparent or subtle ways. For
example, the P4 cluster contains strong enrichment for various
H3K4 methylations while P2 lacks these modifications. On the
other hand, P9 and P12 clusters contain enrichment for the same
chromatin modifications, but the pattern of enrichment is
Author Summary
Recent studies have observed that histone tails can be
modified in a variety of ways. Analyzing a collection of 21
histone modifications, we attempted to determine what
common signatures are associated with different classes of
regulatory elements and whether they mark places of
distinct function. Indeed, at promoters, we identified a
number of distinct signatures, each associated with a
different class of expressed and functional genes. We also
observed several unexpected signatures marking exons
that directly correlate with the expression of exons. Finally,
we recovered many places marked by two distinct
repressive modifications, and showed that they mark
distinct populations of repetitive elements associated with
distinct modes of gene repression. Together, these results
highlight the rich information embedded in the human
epigenome and underscore its value in studying gene
regulation.
Figure 1. Distinct chromatin signatures spanning Refseq promoters. (left) Applying ChromaSig to the histone modifications near 20,389
Refseq promoters recovers 14 frequently-occurring chromatin signatures spanning 18,533 promoters. The heat map represents the enrichment of
H2AZ, 20 histone modifications, CTCF, and RNA polymerase II in the 10-kb region surrounding each promoter. To organize these clusters visually, we
performed hierarchical clustering on the average profiles using a Pearson correlation distance metric. (right) Gene expression data for CD4+ T cells
measured from a previous study [14], and re-visualized here for the different classes of promoters. Shown are the distributions of gene expression
level over promoters with different chromatin signatures. Red horizontal lines indicate the median, the box extends to the lower and upper quartiles,
the whiskers extend to 1.5 times the inter-quartile range, and red ‘‘+’’ symbols are outliers.
doi:10.1371/journal.pcbi.1000566.g001
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region. It is also evident that there is a high level of redundancy of
histone modifications at promoters. Notably, H2AZ, H3K4me1,
H3K4me2, H3K4me3, and H3K9me1 are either all found
together or all absent together at promoters, consistent with
recent findings [4].
Previous studies have shown that there are at least three
different classes of chromatin signatures at promoters: actively
transcribed promoters marked by H3K4me3 but not H3K27me3,
inactive promoters marked with H3K27me3 but not H3K4me3,
and bivalent promoters having both these marks [3]. ChromaSig
recovers all three of these previously known chromatin signatures:
P8–14 have the active chromatin signature, P2 contains the
repressed chromatin signature, and P4 has the bivalent signature.
In agreement with a previous study, we observe that 1379 (7.4%)
promoters in human CD4+ T cells are bivalent, compared to
similar numbers in the differentiated mouse embryonic fibroblasts
(8.6%) but lower than that found in undifferentiated mouse
embryonic stem cells (15.2%).
Next, we wondered if different signatures correspond to
different gene expression activities. On the basis of gene expression
[14], we observe essentially three super-classes of promoters: P1–7
are generally inactive in CD4+ T cells, P9,11,13,14 show
intermediate expression, and P8,10,12 are most highly expressed
(Fig. 1). Promoters with repressed and bivalent chromatin
signatures are generally expressed at low levels, while promoters
with active chromatin signatures have intermediate to high levels
of gene expression. Consistent with the high expression levels, P8,
P10, and P12 also display the most enrichment of the elongation
chromatin mark H3K36me3 (Fig. 1) [12,15]. Interestingly, we
observe chromatin signatures of varying widths of H3K4me3
immediately surrounding transcription start sites. We find that
clusters with larger H3K4me3 widths tend to correspond to higher
gene expression. For example, by visual inspection the average
width in P12 is larger than P10, which is in turn larger than P8,
and which is larger than P9. Strikingly, median gene expression
levels also decrease in the same order.
CpG islands often mark the promoters of house-keeping genes
that are ubiquitously expressed [16,17]. Strikingly, we observe that
each distinct chromatin signature contains promoters that are
either significantly enriched or depleted of CpG islands (Table 1).
Nine of the 14 recovered clusters, containing 66% of all
promoters, are significantly enriched in CpG islands (hypergeo-
metric p-value of 1E-3). The majority of these CpG-enriched
promoters (75%) belong to clusters P8, P9, and P12 containing the
strongest enrichment of H3K4me3. As expected from the high
CpG content, these promoters are also significantly enriched in
Gene Ontology (GO) [18,19] terms relating to ubiquitous
processes such as metabolism and the cell cycle. Another 11% of
the CpG-rich promoters are in cluster P4 containing bivalent
promoters marked by H3K4me3 and H3K27me3. Consistent with
previous studies [3,20], these promoters are enriched in GO terms
relating to human development.
In contrast, clusters P2,5,6,7,11 spanning 34% of all promoters
are significantly depleted of CpG islands. Nearly half of these
promoters are marked by H3K27me3 but not H3K4me3 in
cluster P2. Consistent with previous studies suggesting these
promoters are inactive [3,20], many of these associated genes are
enriched in GO terms relating to development and neurological
processes, which are unrelated to T-cell function. Interestingly, P2
and P4 both mark repressed genes involved in development, but
with distinct sequence context and chromatin signatures. P5 and
P6 are the most CpG depleted clusters, and are not enriched in
any histone modifications studied here. The corresponding genes
are lowly expressed, and are enriched in GO terms unrelated to T-
cells such as secretion and sensory perception [19]. Finally, P11 is
the only CpG-poor cluster enriched with activating chromatin
marks. Consistent with the notion that the corresponding genes
are likely involved in cell-type specific processes [20], these genes
are generally more highly expressed than other CpG poor
promoters, and include T-cell specific genes such as cathepsin
W, which regulates T-cell cytolytic activity, the T-cell specific
protease granzyme A, as well as several lymphocyte antigens
including LY86, CD68, and CD79A.
Table 1. Summary of promoter chromatin signatures P1–14.
Cluster Size Chromatin features P (CpG)* Top GO Biological Process**
P1 208 H3K27me3, H4K20me1 ,1E-16 multicellular organismal dev anatomical structure dev
P2 2896 H3K27me3 1 multicellular organismal dev neurological system proc
P3 204 H3K27me3 ,1E-16 multicellular organismal dev anatomical structure dev
P4 1379 H3K4me3, H3K27me3 ,1E-16 multicellular organismal dev anatomical structure dev
P5 2270 none 1 sensory perception neurological system proc
P6 487 none 1 sensory perception neurological system proc
P7 392 none 1 None
P8 5535 H3K4me3, H4K20me1, H2BK5me1, H3K36me3 ,1E-16 primary metabolic proc cellular metabolic proc
P9 3035 H3K4me3 ,1E-16 primary metabolic proc cell cycle
P10 409 H3K4me3, H4K20me1, H2BK5me1, H3K36me3 ,1E-16 regulation of biological proc regulation of cellular proc
P11 219 H3K4me1 1 None
P12 575 H3K4me3, H4K20me1, H2BK5me1, H3K36me3 ,1E-16 primary metabolic proc biopolymer metabolic proc
P13 472 H3K4me3, H4K20me1 ,1E-16 multicellular organismal dev cell differentiation
P14 452 H3K4me3 8.43E-04 None
* P(CpG) is the hypergeometric probability of finding more CpG-marked promoters than observed, as compared to the background distribution of all promoters.
** Selected Gene Ontology terms from the Biological Processes ontology significantly enriched with Benjamini-corrected p-value of 0.001. Abbreviations: dev,
development; proc, process.
doi:10.1371/journal.pcbi.1000566.t001
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distinct chromatin signatures at promoters with unique functional
specificities.
Distinct chromatin signatures at known regulatory
elements
While transcriptional regulation occurs at the level of promot-
ers, it is also clear that the action of promoter-distal regulatory
elements is essential to controlling gene expression [1]. Like
promoters, the activity of these regulatory elements is likely
dependent on chromatin structure. To determine what chromatin
signatures exist at distal regulatory elements, we apply ChromaSig
to several classes of regulatory elements in turn: enhancers,
insulators, Refseq 39 ends, and DNase I hypersensitive sites.
Enhancers. When active, enhancers are bound by tran-
scription factors and co-activators to increase gene expression at
promoters [21,22]. Previously, we observed that enhancers are
marked by strong enrichment of H3K4me1 and weak if any
enrichment of H3K4me3, allowing us to develop a computational
strategy to identify enhancers using this chromatin signature [6].
Applying this method to the genome-wide profiles of H3K4me1
and H3K4me3 in CD4+ T cells [12], we predict 32,237 promoter-
distal enhancers (see Methods). To validate these enhancer
predictions, we compare to two hallmarks of enhancers: DNase I
hypersensitivity and sequence conservation. Almost half (44.5%)
of the enhancer predictions are within 1-kb of a DNase I
hypersensitive site [23], and about three-fourths of the predictions
are recovered by some combination of hypersensitivity and
conserved DNA sequence elements from the PhastCons database
[24].
We have previously observed in 1% of the human genome (the
ENCODE regions) that different variations of chromatin modifi-
cations exist at enhancers [25]. To assess if this is true on a global
scale, we apply ChromaSig to align and cluster these predicted
enhancers over the entire panel of chromatin modifications. This
reveals 11 distinct chromatin signatures, all of which contain
stronger enrichment for H3K4me1 than H3K4me3 (Fig. S4,
Table S2). Like promoters, there also appears to be much
redundancy of chromatin modifications at enhancers. For
example, all chromatin signatures generally share enrichment
for H2BK5me1, H3K4me2, H3K9me1, H3K27me1, and
H3K36me1. Interestingly, the chromatin marks H2A.Z and
H4K20me1 appear to be inversely correlated: E1-5 are enriched
in H2A.Z but not H4K20me1, E6 has enrichment of both marks,
and E7–11 are enriched in H4K20me1 but not H2A.Z.
Insulators. CTCF is an insulator binding protein in
mammals, and when bound prevents enhancers from interacting
with promoters, thereby preventing activation [26]. Barski et al
mapped CTCF binding in CD4+ T cells [12], and application of
the Model-based Analysis of ChIP-Seq (MACS) peak finder
reveals 27,110 CTCF binding sites genome-wide (see Methods)
[27]. To focus on novel chromatin signatures, we apply
ChromaSig to the 17,328 CTCF sites distal to (at least 2.5-kb)
Refseq TSSs and predicted enhancers, revealing seven distinct
signatures (Fig. S5, Table S3). The only consistent feature of
CTCF binding sites is enrichment of H2A.Z, consistent with
previous observations [28]. However, unlike the patterns observed
at promoters and enhancers, enrichment for other chromatin
marks at CTCF binding sites is generally weak, suggesting that the
remaining panel of chromatin marks do not functionally
compliment CTCF. The exceptions are C4 and C5, which
contain enrichment of H3K4me3 and RNA Pol II, suggesting that
these CTCF binding sites may fall within promoters not yet
annotated in the Refseq database.
Refseq 39 ends. Transcription of pre-mRNA stops at the 39
end of the gene. To find chromatin signatures at this genomic
feature, we apply ChromaSig to 16,703 Refseq gene 39 ends distal
to Refseq 59 ends [13]. We recover 12 distinct chromatin
signatures. Like CTCF binding sites, enrichment of chromatin
marks at Refseq 39 ends is generally weak. In agreement with
Barski et al [12], the most consistent feature found at the majority
of 39 ends is enrichment of H3K36me3, found in T1–7 (Fig. S6,
Table S4). However, chromatin signatures at 39 ends are not as
well aligned as those at promoters, suggesting that these chromatin
signatures may occur at some other genomic feature near 39 ends,
or that the 39 ends are not as well annotated as promoters.
DNase I hypersensitive sites. Recently, Boyle et al mapped
nearly 100,000 DNase I hypersensitive sites genome-wide in
CD4+ T cells using DNase-Seq [23]. Since DNase I
hypersensitivity is a hallmark for active regulatory loci, we
expect to find chromatin signatures at these sites. Applying
ChromaSig to the 31,824 DNase I hypersensitive sites distal to
Refseq TSSs, predicted enhancers, and CTCF binding sites, we
recover 13 clusters (Fig. S7, Table S5). Clusters D1–D2 are only
enriched in H3K27me1 and H3K36me3, resembling gene 39
ends. Several signatures D3–10 display characteristic enrichment
of H3K4me1/2/3, which we have observed at promoters and
enhancers. These may be novel promoters or enhancers missed by
the enhancer prediction method. For example, D3,6,9,10 are
clusters with the strongest enrichment of H3K4me3, and 31.2% of
these loci are recovered by multiply-occurring CAGE tags [29], an
almost 4-fold enrichment as compared to an expected recovery of
7.9% over random loci. The majority of DNase I sites D11–13
contain no noticeably strong enrichment of any chromatin mark,
suggesting either that there are no other major classes of
epigenetically-marked regulatory elements in the human genome
or that they are marked by modifications not studied here.
Several clusters of enhancers correlate with gene activity
In eukaryotes, control of gene expression is a complex process
involving the coordinated action of a wide assortment of genomic
regulatory elements. Of the five classes of genomic regulatory
elements examined here, the ones least studied and perhaps most
important to controlling gene expression are enhancers and
DNase I hypersensitive sites. To examine the potential regulatory
roles of these genomic loci, we measure the enrichment of these
loci near different classes of expressed genes as defined by the 14
clusters of promoter chromatin signatures (Fig. 1).
When a CTCF-bound insulator falls between a promoter and
enhancer, the enhancer is blocked from activating the promoter
[26]. As this mechanism may also apply to regulatory elements
outside of enhancers, we partition the genome into CTCF-defined
blocks and determine enrichment of chromatin signatures having
promoters in the same CTCF-defined block (Fig. S8). At a large
scale, we observe that inactive promoters P1–6 generally lack
enrichment for all the chromatin signatures cataloged here. In
contrast, CTCF-defined domains containing active promoters
P8–14 are enriched in numerous chromatin signatures. Strikingly,
different classes of promoters are enriched in different classes of
enhancers. For example, the two most highly expressed clusters
P10 and P12 are uniquely enriched in E6–11. These enhancers are
distinguished from other enhancer classes by strong enrichment of
H3K9me1 and H4K20me1, indicating that these chromatin
marks may be an indicator of enhancer activity. Of these
enhancers, the class that most distinguishes highly active
promoters from all other promoters is E9. This cluster may
contain the most active enhancers, and its chromatin signature
may be a general mark for highly active enhancers. In general, we
Functional Chromatin Signatures
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within CTCF-defined blocks containing highly expressed promot-
ers, with the exception of D6–8 which are likely enriched in novel
promoters and enhancers missed by the enhancer prediction
method.
Distinct chromatin signatures distal to known regulatory
regions
Having observed chromatin signatures at regulatory elements
including promoters and enhancers, we next ask if other
chromatin signatures exist that mark loci distal to known
regulatory elements. By definition, places in the genome with
chromatin signatures contain enrichment of histone modifications.
Therefore, we identify 85,318 loci with strong ChIP enrichment of
histone modifications, of which 50,183 are distal to promoters
[13], gene 39 ends [13], DNase I hypersensitive sites [23], CTCF
binding sites [12], and sites containing an enhancer chromatin
signature [6,7]. Applying ChromaSig to these sites, we recover 7
frequently-occurring chromatin signatures, named U1–7 (for
unannotated clusters 1 to 7), spanning 47,874 loci (Fig. 2,
Table 2, Table S6). The recovered signatures are distinct from
the previously defined H3K4me3-rich promoter and H3K4me1-
rich enhancer signatures [3,6]. Compared to chromatin signatures
from randomly aligned and oriented loci, the chromatin signatures
observed are significantly better aligned than expected by chance
(p-values ranging from 10
218 to ,10
2300)( Table S7).
The most prominent chromatin feature of these clusters is
H3K36me3, known to mark the 39 ends of genes [12] and more
recently exons [8], and it is enriched at U1, U2, and U4 clusters.
The largest clusters recovered, U5 and U6, both contain
enrichment of known repressive chromatin modifications includ-
ing H3K9me2, H3K9me3, H3K27me2, and H3K27me3 [12].
Chromatin signatures mark exon 59 ends
To gain an understanding of potential functions associated with
the above frequently-occurring novel chromatin signatures, we
compare the loci bearing each signature to genomic annotations.
H3K36me3 is known to be enriched within the body of
transcriptionally active genes [30,31], notably towards the 39 ends
[12]. But since all the clustered loci are distal to gene 39 ends, the
H3K36me3-rich clusters must be marking another genomic
feature. Noticing that the vast majority of loci in U1–4 are
intragenic (Fig. S9), we ask if these sites are biased towards exons
or introns. We observe that 57.9% of U1 sites and 63.8% of U2
sites are either inside exons or within 1-kb of exon ends, while at
random only 26% of the genic regions of the genome match these
criteria. To see if H3K36me3 marks exons, we examine the
enrichment of this chromatin mark at exons (Fig. S1). To examine
only those exons unambiguously marked by a chromatin
signature, we only consider an exon if it is the only exon within
1-kb of a cluster locus. We observe a striking enrichment of
H3K36me3 at the 59 ends of exons unambiguously marked by U1,
U2, and U4. This enrichment decreases sharply upstream of the 59
end, but more gradually into the exon body. This observation also
holds for exons larger than 1-kb (Fig. S2), indicating that the
result is not biased by the relatively small exon sizes in the human
genome [32]. These results suggest that the clusters with strong
H3K36me3 enrichment mark exon 59 ends.
H3K36me3 reflects exon expression levels
Having observed H3K36me3 at a handful of exons, we next
ask if this chromatin mark is a global indicator of exon
expression. First, we examine the enrichment of clusters U1–4
within the gene bodies belonging to the promoters in clusters
P1–14. Indeed, we find that clusters U1–4 are enriched within
t h eg e n eb o d i e so fh i g h l ye x p r e s s e dg e n e sb e l o n g i n gt op r o m o t e r
classes P8–P14, but are depleted in the gene bodies of inactive
promoters in other classes (Fig. S8). Next, profiling H3K36me3
at a catalog of more than 250,000 distinct exons [33], we observe
that the majority of exons (72.6%) have more than two-fold
enrichment for H3K36me3 tags than neighboring introns
(Fig. 3A). In the direction of transcription, H3K36me3
enrichment increases sharply at the 59 end of the exon, and
decreases more gradually in the body of the exon, in agreement
with our previous observations. In contrast, neighboring introns
show no such chromatin signature (Fig. 3, S10). The presence of
this chromatin mark also correlates strongly with exonic
expression (Fig. 3), as measured previously by exon expression
arrays in CD4+ T cells [34]: highly expressed exons having more
H3K36me3 enrichment than lowly or moderately expressed
exons. Altogether, these results suggest that H3K36me3 is a
general mark of exon expression.
Stable nucleosome structure at exon 59 ends
Recently, it has also been observed that H3K36me3 marks
exons in various eukaryotes, though the modification was found to
be biased toward the 39 ends of exons [8]. To resolve this
discrepancy, we take advantage of a unique feature of ChIP-Seq
technology, which sequences short directional reads directly
upstream and downstream of the genomic DNA bound by the
protein of interest, allowing clear distinction between sense and
anti-sense reads. This information can be used to offer
unprecedented resolution of in vivo binding locations of the
immunoprecipitated protein [27,35]. We can also use this
information to more finely resolve nucleosome structure at exons.
Examining the distribution of H3K36me3 tags near the top 50%
expressed human exons, we observe that reads on the sense strand
peak at the 59 ends of exons, whereas reads on the anti-sense
strand peak about 150 base pairs downstream (Fig. 3B). These
results suggest that a well-positioned nucleosome modified by
H3K36me3 exists at the 59 ends of expressed exons, and consistent
with this conclusion the spacing between sense and anti-sense
peaks is roughly the size of a nucleosome.
In addition to exon 59 ends, it also appears that the 39 ends of
expressed exons have well-positioned nucleosomes (Fig. 3C). But
given that a typical nucleosome wraps between 145 and 147 bp of
DNA [36], which is roughly the same size as the average human
exon at 145 bp [32], it is difficult to conclude from these
observations whether the nucleosomes harboring H3K36me3 are
more fixed towards exon 59 or 39 ends. To resolve this issue, we re-
examine the distribution of H3K36me3 reads, but focus on
expressed exons larger than 500 bp (Fig. 3D–E). Again, we
observe sense and anti-sense peaks at exon 59 ends indicative of
well-positioned modified nucleosomes, followed by a decrease of
H3K36me3 enrichment on both strands in the direction of
transcription. However, we also find similar but weaker peaks on
both strands at exon 39 ends, with the sense strand peaking about a
nucleosomal distance upstream of the anti-sense strand (Fig. 3E).
Thus, we conclude that the nucleosomes harboring H3K36me3
are found at both 59 and 39 ends of exons, but the enrichment is
stronger at the 59 ends. To test this conclusion more globally over
a larger collection of exons, we also examine the enrichment of
H3K36me3 along the exon body as a function of exon length.
Indeed, as exon length increases, we observe enrichment of
H3K36me3 at 59 and weaker enrichment at 39 exon ends,
separated by the exon body lacking enrichment (Fig. S11).
Functional Chromatin Signatures
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As H3K36me3 at the 59 ends of exons is a global mark of exon
expression, we next wondered if the presence of this mark
correlates with alternative splicing. A previous study found that the
density of H3K36me3 at canonical exons is higher than that at
alternative exons in mice [8]. As this observation did not
incorporate expression information but instead relied on static
exon definitions, the question of whether the presence of
H3K36me3 correlates with exonic splicing in humans remains
unanswered. To answer this question, we investigate alternative
splicing on a global scale by focusing on a list of 13,434 exons
known to be alternatively spliced as cassette exons (UCSC
Genome Browser ‘‘knownAlt’’ track) [37]. We examine two sets
of transcripts using exonic expression information. The ‘‘spliced
in’’ set consists of cassette exons expressed at levels similar to
neighboring upstream and downstream exons (|Dexpr|=0.5),
Figure 2. Distinct chromatin signatures spanning genomic loci distal to known regulatory elements. We identified 50,183 genomic loci
with strong ChIP enrichment of histone modifications but distal to promoters, gene 39 ends, DNase I hypersensitive sites, CTCF binding sites, and
predicted enhancers. Applying ChromaSig to these loci reveals seven clusters U1–7 spanning 47,874 loci. The heat map represents the enrichment of
H2AZ, 20 histone modifications, CTCF, and RNA polymerase II in the 10-kb region surrounding each locus. To organize these clusters visually, we
performed hierarchical clustering on the average profiles of each ChromaSig cluster, using a Pearson correlation distance metric (left).
doi:10.1371/journal.pcbi.1000566.g002
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contrast, the ‘‘spliced out’’ set consists of cassette exons expressed
at lower levels than both upstream and downstream exons, and are
likely excluded from the mature transcript (exprup,down2
expralt.1). For spliced in exons, we observe that the enrichment
of H3K36me3 increases gradually from upstream to alternatively
spliced to downstream exons (Fig. 4A), consistent with previous
results showing a 39 bias in this chromatin mark [12]. However,
H3K36me3 is noticeably depleted at spliced out exons as
compared to both upstream and downstream exons (Fig. 4B).
These results suggest that, on a global scale, the presence of
H3K36me3 at alternatively spliced exons correlates with inclusion
of the exon in transcripts.
In agreement with these observations, we find that exons marked
by U1 or U2 are preferentially included in mature mRNAs
(pU1=1.65E–26, pU2=5.94E–43, Wilcoxon rank sum test) (Fig.
S3). U3, which contains no H3K36me3 enrichment (Fig. 2, S1), is
a negative control containing no preference of exon inclusion.
Interestingly, exons marked by U4, which are enriched in the
repressiveH3K9me3 modification, are preferentially excluded from
mature mRNAs (pU4=6.67E–4, Wilcoxon rank sum test). Taken
together, these results suggest that several distinct chromatin
signatures are found at exon 59 ends, that some signatures mark
exons for preferential inclusion, and others for preferential
exclusion. These different functional specificities may be attributed
to specific differences in chromatin signatures (see Discussion).
H2BK5me1 and H4K20me1 mark highly expressed 59
exons
Our initial scan revealed several classes of chromatin signatures
marking exons, the largest of which are U1 and U2. Both of these
contain enrichment for H3K36me3, but U1 contains stronger
enrichment for H2BK5me1 and H4K20me1. This latter modifi-
cation is known to be localized both at promoters and intragenic
regions downstream of the promoters, with enrichment fading in
the gene body [12]. These observations raise the possibility that
exons marked by U1 are exons closer to promoters (59 exons) while
U2 are exons closer to the 39 ends of genes (39 exons). To test this
hypothesis, we partition the highly expressed exons above into first
and non-first exons. Non-first exons are further subcategorized
into early, middle, and late exons based on distance from the
transcription start site (TSS). We then examine the enrichment of
histone modifications near these different classes of exons (Fig. 5).
As expected, first and early exons, which are closest to TSSs, are
all highly enriched in promoter modifications including
H3K4me1, H3K4me2, and H3K4me3. In addition to
H3K36me3, it is clear that there is also a general peak of
H2BK5me1 and H4K20me1 enrichment at exons. This enrich-
ment is most pronounced in 59 exons compared to first, middle,
and 39 exons. In addition, we also observe that 59 exons, while still
marked by H3K36me3, have weaker enrichment of this mark
compared to mid or 39 exons, but is clearly more enriched than
the first exon. H3K36me3 enrichment increases with increasing
distance from the TSS, consistent with above results (Fig. 4A) and
previous observations [12]. These results provide additional
evidence for various chromatin modifications marking distinct
exons in the human genome.
Distinct classes of repressive chromatin signatures
In addition to chromatin signatures U1–4, ChromaSig also
identifies two new chromatin signatures, U5–6, having strong
enrichment of repressive histone modifications (Fig. 2). Consis-
tently, these signatures are not found near highly expressed genes
but are enriched near repressed genes (Fig. S8). These two
chromatin signatures are distinct, with U5 having stronger
enrichment of repressive modifications H3K9me2 and
H3K9me3. This subtle difference prompted us to ask if these
signatures mark distinct regions of the genome. Indeed, we find
that only 23.3% of U5 loci are intragenic, a notable depletion over
the expected value of about 40% (Fig. S9). In contrast, U6 loci are
closer to the expected value at 36.3% intragenic.
Additional analysis suggests that the sequences underlying U5
and U6 fragments are associated with distinct properties. First, we
compare to the PhastCons database containing over 2 million
conserved elements in the human genome conserved over 28
mammalian genomes [24]. We find that U5 loci are significantly
depleted of conserved elements (p=7.12E–182) while U6 is
significantly enriched (p=2.09E–26) (Fig. 6A). Given that
repressive histone modifications have been known to mark
repetitive regions of the genome [38] which are highly lineage-
specific [32], the low conservation of U5 loci may be explained by
enrichment for repetitive sequences. To test this hypothesis, we use
RepeatMasker [39] to define repetitive bases within 61-kb from
each locus in U5–6. Indeed, 49.1% of U5 bases are repetitive, as
compared to 32.1% of U6 bases (Fig. 6B), suggesting that these
two clusters may harbor different classes of sequences. To pursue
this further, we next ask if the classes of repeats found in U5 are
different from those found in U6. Counting the repetitive elements
found within 61-kb of each locus (Fig. 6C,D), we find that U5 is
significantly enriched for long terminal repeats (LTR) (p,1E–300,
Z-score=39.7), while U6 is neither enriched nor depleted. For the
SINE family of repeats, while both clusters are significantly
depleted in Alu repeats (pU5,1E–300, ZU5=81.5; pU6=4.76E–
245, ZU6=33.4), only U6 is notably enriched in MIR repeats
(p=2.31E–177). Similarly, L2 LINE repeats and simple repeats
are notably more enriched in U6 loci than U5 loci. These results
suggest that U5 and U6 have different genic distributions and
mark distinct sequences of the genome.
U5 and U6 mark different domains of gene repression
We next examine whether the different genic distributions and
sequence preferences of U5 and U6 relate to gene expression. It is
thought that the genome is organized into different domains of
transcriptional activity, with the insulator binding protein CTCF
defining the boundaries of these domains [26]. Therefore, we
partition the genome into CTCF-defined domains and determine
the enrichment of U5 or U6 loci in these domains as a function
promoter activity. The distributions of U5 and U6 enrichment are
significantly different (p=5.95E–26, paired Wilcoxon signed rank
test) (Fig. 7A): U5 is more enriched than U6 in domains
containing the most repressed genes (log expression ,4), while
domains containing genes more expressed (log expression between
Table 2. Summary of chromatin signatures U1–7.
Cluster Number Chromatin features Association
U1 2845 H3K36me3, H2BK5me1, H4K20me1 Exons
U2 3742 H3K36me3 Exons
U3 615 H2BK5me1, H4K20me1 ?
U4 961 H3K36me3, H3K9me3 Exons
U5 34368 H3K9me3, H3K27me3 Repressed regions
U6 4394 H3K27me3 Repressed regions
U7 949 H2AZ ?
doi:10.1371/journal.pcbi.1000566.t002
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PLoS Computational Biology | www.ploscompbiol.org 7 November 2009 | Volume 5 | Issue 11 | e1000566Figure 3. H3K36me3 marks exon 59 ends and is a global mark of expression. (A) The top panel is a heat map of H3K36me3 enrichment at all
human exons, sorted by exonic expression (right). The bottom panel is the average H3K36me3 enrichment profile of the lowest, middle, and highest
third of expressed exons from the top panel. The distribution of H3K36me3 reads within 6500 bp of exon (B) 59 ends and (C) 39 ends of the top 50%
expressed exons in the human genome. In red are reads on the sense strand in the direction of transcription, and in green are anti-sense reads. A
schematic of a positioned a nucleosome is shown. (D–E) As in (B–C), but focusing on expressed exons longer than 500 bp.
doi:10.1371/journal.pcbi.1000566.g003
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moderately and highly expressed genes (log expression .6), the
enrichment of both U5 and U6 loci are depleted relative to
random. We next investigate the localization of U5 and U6 with
respect to the distinct promoter classes P1–14. We find that U5–6
are in general depleted near moderately and highly expressed
promoters P8–14. In contrast, U5 and U6 are enriched near
distinct classes of repressed genes. U6 is enriched in CTCF blocks
containing P1 and P3 compared to U5 (Fig. S8). In contrast, U5 is
enriched near promoters in cluster P6, which are depleted of U6
elements (Fig. S8). These results further underscore the notion
that these elements repress the genome in distinct ways.
While it is not surprising that U5 and U6 are enriched near
genes with low expression since they are both enriched in
repressive histone modifications, it is remarkable that these two
chromatin signatures mark distinctly different populations of lowly
expressed genes. One possibility is that U5 and U6 are present in
different compartments of the nucleus. To test this, we examine
the localization of these loci in lamina-associated domains (LADs),
previously mapped in fibroblast cells and known to contain
repressed genes and gene deserts. Indeed, more than 60% of U5
loci are in LADs (penrichment,1E–300), compared to only 37.4%
for U6 loci (pdepletion=1.57E–10) (Fig. 7B). Taken together, these
results suggest that U5 and U6 mark distinct domains of gene
expression that may be explained by their enrichment in different
nuclear compartments.
Discussion
In this study, we survey the global landscape of commonly
occurring chromatin signatures in the human genome. We recover
known signatures at well-studied elements such as promoters and
lesser-studied elements including enhancers. In addition, we find 7
distinct signatures spanning 47,874 genomic loci distal to known
regulatory elements. We observe chromatin signatures marking
exons and show at a higher resolution that the 59 ends of exons are
specifically modified by H3K36me3. Furthermore, we show that
the enrichment level of this mark directly correlates with exonic
expression, a result that had only been implied before. In addition,
we recover two distinct chromatin modifications U1 and U2
marking exons in our genome-wide scan. While both are enriched
in H3K36me3, U1 is uniquely enriched in H2BK5me1 and
H4K20me1, which directly coincides with U1 marking early exons
and U2 marking late exons.
A previous study by Kolasinska-Zwierz et al also observed that
H3K36me3 marks exons in C. elegans and in mammals [8]. Here,
we find that this histone modification is specifically enriched at the
59 ends of exons and also weakly enriched eat 39 ends of exons.
Our results, together with findings by Kolasinska-Zwierz et al,
implicate chromatin modifications in regulating splicing, a process
until recently thought to be decoupled from transcription both
physically and temporally. In yeast, H3K36me3 is deposited by
the histone methyltransferase Set2, which is associated with the
elongation form of RNA polymerase [40,41]. The observation that
H3K36me3 marks exons, a part of gene structure in the realm of
splicing rather than transcription, implies that H3K36me3 may
directly or indirectly regulate splicing.
A large body of work on splicing regulation has been focused on
how sequence-specific proteins binding directly to pre-mRNAs
affect splicing [42,43]. But the static and highly degenerate natures
of sequence elements associated with splicing leave unanswered
the question of how cell-type specific splicing is achieved.
Figure 4. H3K36me3 enrichment correlates with alternative splicing. The number of H3K36me3 reads per kilobase for exons near
alternatively spliced cassette exons that are (A) spliced in or (B) spliced out. A cassette exon is defined to be spliced in if the difference in expression
between it and its immediate upstream and downstream exons is less than 0.5 on a log2 scale. A cassette exon is defined to be spliced out if both
upstream and downstream exons are at least 2-fold more expressed (1.0 on a log2 scale).
doi:10.1371/journal.pcbi.1000566.g004
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the splicing machinery has shifted attention to the roles of the
transcription machinery in regulating splicing [42,44]. This has led
to two models describing co-transcriptional splicing: a kinetic
model and a recruitment model [42]. While both models
emphasize spliceosome activity during transcription, neither fully
explains how cell-type specific splicing is achieved. Our observa-
tions that distinct chromatin signatures are present at exons, and
that different signatures are associated with either inclusion or
exclusion from mature mRNAs, suggest a role of chromatin state
in splicing regulation. One possibility is that the writing and
reading of dynamic chromatin signatures may direct splicing
events. While this model is attractive, further studies will be
necessary to verify this hypothesis.
Identifying alternatively spliced exons de novo using chromatin
signatures is an exciting possibility. A recent study has used the
enrichment of H3K4me3 in conjunction with proximal enrich-
ment of H3K36me3 to identify novel long non-coding RNAs
[45], though H3K36me3 enrichment was used more as an
indicator of elongation than ofe x o nb o u n d a r i e s .B u te v e ni f
chromatin signatures can be used to detect alternative exons,
because exons are transcribed it would be as cheaper, more
efficient, and more reliable to employ techniques such as RNA-
Seq to completely enumerate alternative exons de novo [46]. In the
future as we approach completely mapping all histone modifi-
cations of the epigenome, one interesting possibility is that, like
promoters and enhancers [3,7], an exon chromatin signature
marking poised but inactive exons may also exist. This could
Figure 5. H2BK5me1 and H4K20me1 mark early exons. (A) Shown is a heat-map representing the enrichment of various modifications and
factors in a 5-kb region surrounding the top third expressed exons. The exons are separated into (top) first exons and (bottom) non-first exons, and
are then sorted by distance from the transcription start site. Non-first exons are further subcategorized into early, middle, and late exons. (B) The
average profiles for (left) H2BK5me1, (middle) H3K36me3, and (right) H4K20me1 for first, early, middle, and late exons.
doi:10.1371/journal.pcbi.1000566.g005
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PLoS Computational Biology | www.ploscompbiol.org 10 November 2009 | Volume 5 | Issue 11 | e1000566Figure 6. U5 and U6 mark distinct sequences of the genome. (A) The percentage of loci in U5 and U6 within 1-kb to an evolutionarily
conserved PhastCons element. (B) The average percentage of bases 61 kb around each locus that are masked by RepeatMasker. (C–D) The number
of repeat elements within 61 kb of each locus in (C) U5 and (D) U6. Black indicates the observed value while grey indicates the expected value over
random sites. The error bars indicate 61 standard deviation. LTR, long terminal repeat; simple, simple repeat.
doi:10.1371/journal.pcbi.1000566.g006
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response to stimuli.
We also recover several chromatin signatures enriched in
repressive histone modifications marking distinct populations of
repetitive elements. Surprisingly, these signatures are associated
with different modes of gene repression. One possible explanation
for this phenomenon is that U5 loci, which contain H3K9me2 and
H3K9me3, are more highly enriched in nuclear lamina-associated
domains than U6 loci. Thus the U5 chromatin signature may be
specifically associated with LADs, while U6 is with other types of
domains. It is possible that these two different types of chromatin
domains correlate with distinct mechanisms of gene silencing, with
H3K9-associated U5 domains being more permanently repressed
than H3K9-free U6 domains.
These results show that studying the human genome on the
basis of chromatin signatures is a useful method to cataloging
regulatory elements in the genome in a global, unbiased, and
systematic way. Future efforts to map chromatin modifications in
the human genome may allow us to define more chromatin
signatures marking novel regulatory elements or different
functional specificities of known regulatory elements.
Methods
Data normalization. Genome-wide distributions of histone
modifications were obtained from Barski et al [12]. As in Hon et al
[5], we filtered reads for uniqueness and redundancy, partitioned
the genome into 100-bp bins, and counted reads in each bin. As the
number of reads for each mark was highly variable, normalization
was necessary to facilitate comparison. For each bin i and mark h,
we normalized the number of reads in this bin xh,i as in [5]:
xnorm
h,i ~
1
1ze
{ xh,i{median xh ðÞ ðÞ =std xh ðÞ
Genome annotations. Genome annotations were download-
ed from the UCSC Genome Browser [37], human genome Build
36.1 (hg18 assembly). Gene definitions were given by the Refseq
Genes [13] track. CpG island definitions were given by the ‘‘CpG
Islands’’ track. Alternatively spliced exons were defined by entries
in the ‘‘Alt Events’’ track labeled as ‘‘Cassette Exons’’. The list of
human loci conserved in a 28-way alignment with placental
mammals was defined by the phastConsElements28wayPlacMam-
mal table[24]. Repeat definitions were given by the RepeatMasker
track [39], and lamina-associated domains mapped in Tig3 human
lung fibroblasts [47] were defined by the ‘‘NKI LADs’’ track.
Catalogs of regulatory elements. Using previously pub-
lished CTCF ChIP-Seq data [12], we obtained a list of 27,110
CTCF sites by running the Model-based Analysis of ChIP-Seq
[27] software with default parameters and a p-value cutoff of
1E–5. We used normalized H3K4me1 and H3K4me3 profiles (as
above) to predict enhancers as in Heintzman et al [6]. ROC
analysis indicated that using a p-value cutoff of 0.1 gives optimal
recovery (in terms of sensitivity and positive predictive value) of
DNase I hypersensitive sites [23], corresponding to 32,237
predicted enhancers at least 2.5-kb from Refseq TSSs.
Finding ChIP-enriched loci distal to known regulatory
elements. As in Hon et al [5], we identified regions of width 2-kb
containing enrichment for histone modifications. We modeled the
background distribution using 1% of the human genome as
defined by the ENCODE regions and defined enriched regions as
those significantly deviating (p=0.0001) from the background. To
remove redundancy, we removed any enriched locus closer than
2.5 kb to another enriched locus. We then removed loci within
2.5 kb to regulatory loci at promoters [13], gene 39 ends [13],
CTCF binding sites [12], DNase I hypersensitive sites [23], and
sites having an enhancer chromatin signature [6].
Finding chromatin signatures. We searched for chromatin
signatures of width 4-kb using ChromaSig [5] with a background
prior p2A=0.01 and a standard deviation factor sanother=1.75. For
loci with well-defined loci (gene 59 ends, gene 39 ends, CTCF
binding sites, DNase I hypersensitive sites) we searched within a
region 6500-bp around the sites, but for less-defined loci
(predicted enhancers, ChIP-rich regions) we relaxed the search
to a 61-kb region. To focus only on the most frequently-occurring
chromatin signatures, we analyzed only those clusters output
having at least 500 loci and an average normalized enrichment
greater than 0.25 for at least one modification.
Chromatin signature significance. For a given cluster of
size N, we defined the motif mh,i to be the mean normalized
enrichment of the aligned loci at a specified position i for
modification h. Well-aligned motifs have higher values of
enrichment. For each motif, we computed the score:
S~
X
h
max
j
mh,j
  
Figure 7. U5 and U6 mark distinct expression domains of the
genome. (A) Enrichment of U5 and U6 loci as a function of expression
for genes in the same domain. We counted the number of U5 and U6
loci within the CTCF-defined domains containing human promoters,
assessed enrichment as compared to that expected over random sites,
and averaged over a 1000-promoter sliding window to create each
profile. The signed rank p-value is indicated. (B) The percentage each
cluster within lamina-associated domains, previously mapped in Tig3
human lung fibroblasts (black), as compared to random sites (grey). The
error bars indicate 61 standard deviation.
doi:10.1371/journal.pcbi.1000566.g007
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PLoS Computational Biology | www.ploscompbiol.org 12 November 2009 | Volume 5 | Issue 11 | e1000566Higher values of S indicate more significant motifs. To assess
significance of observing a motif spanning N loci with score S or
greater, we randomly sampled 100 sets of clusters with random
alignment offsets (within 61 kb of the aligned sites) and
orientations (positive or negative strand), computed S scores for
each random set, and modeled the random distribution of S scores
as a Guassian distribution to allow for calculation of significance.
We performed this randomization either within loci in the same
cluster as the original motif or over loci from all clusters.
Heatmaps. All heatmaps consist of normalized data over 100-
bp bins (see above), and were visualized using Java TreeView [48].
Expression data. Transcript and exon expression data were
measured in CD4+ T cells by Crawford et al [14] (GEO accession
GSE4406) and Oberdoerffer et al [34] (GEO accession
GSE11834), respectively. Both studies performed duplicate
measurements on microarrays, and the expression data shown
here is the average of the replicates.
Randomization. To determine enrichment for a given
cluster, we compared to 100 random clusters. Each random
cluster contains the same number of loci as the original cluster and
follows the same chromosomal distribution. Random sampling is
limited to bins containing ChIP-Seq reads.
Statistical tests. To assess significance of overlap with known
genome annotations, we assume that the overlap statistics for 100
random clusters follows a Gaussian distribution. To assess
significance of exon inclusion for marked versus unmarked exons,
we use a two-sided Wilcoxon rank sum test to compare the median
exon expression of the two sets. To assess that U5 and U6 are
enriched near different classes of expressed genes, we use the
paired two-sided Wilcoxon signed rank test to compare the
enrichment profiles.
Supporting Information
Figure S1 U1, U2, and U4 mark exon 59 ends. An exon is
unambiguously marked if it is the only exon within 1-kb of a
genomic locus. We profiled chromatin enrichment relative to the
59 ends of unambiguously marked exons for clusters (a) U1, (b) U2,
(c), U3, and (d) U4. The top panels are heat maps representing the
H3K36me3 enrichment in a 10-kb region surrounding the 59 ends
of unambiguously marked exons. The bottom panels represent the
average profiles of the heat maps. U3 is the negative control.
Found at: doi:10.1371/journal.pcbi.1000566.s001 (0.89 MB TIF)
Figure S2 U1 and U2 mark the 59 ends of exons greater than
1-kb in length. An exon is unambiguously marked if it is the only
exon within 1-kb of a genomic locus. We profiled chromatin
enrichment relative to the 59 ends of unambiguously marked exons
of length .1-kb for clusters U1 and U2. The top panels are heat
maps representing the H3K36me3 enrichment in a 10-kb region
surrounding the 59 ends of unambiguously marked exons. The
bottom panels represent the average profiles of the heat maps.
Only a small number of U3- and U4-marked unambiguous exons
are larger than 1-kb, and so are not shown here.
Found at: doi:10.1371/journal.pcbi.1000566.s002 (0.76 MB TIF)
Figure S3 Chromatin signatures associated with preferential
inclusion and exclusion of exons into mature mRNAs. (a)
Schematic of a gene containing an exon marked by a chromatin
signature in pink and an unmarked alternatively spliced exon in
green. After transcription and splicing, mature mRNAs either
have one exon or the other. We compared exonic expression for
marked exons in pink versus unmarked alternatively spliced exons
in green for (b) U1, (c) U2, (d) U3, and (e) U4. The overlap is in
brown. Wilcoxon rank sum p-values are indicated. Red p-values
indicate enrichment of marked over unmarked exons, while green
p-values indicate enrichment of unmarked over marked exons. U3
is the negative control.
Found at: doi:10.1371/journal.pcbi.1000566.s003 (0.85 MB TIF)
Figure S4 Distinct chromatin signatures spanning predicted
enhancers. On the basis of a previously published enhancer
chromatin signature having strong H3K4me1 enrichment but
weak H3K4me3 enrichment, we predicted 32,237 promoter-
distal enhancers. Applying ChromaSig to these loci using the full
panel of chromatin modifications mapped by Barski et al., we
recovered 11 clusters. The heat map represents the enrichment of
H2AZ, 20 histone modifications, CTCF, and RNA polymerase II
in the 10-kb region surrounding each enhancer prediction. To
organize these clusters visually, we performed hierarchical
clustering on the average profiles using a Pearson correlation
distance metric (left).
Found at: doi:10.1371/journal.pcbi.1000566.s004 (3.73 MB TIF)
Figure S5 Distinct chromatin signatures spanning promoter-
distal and enhancer-distal CTCF binding sites. We used MACS
[10] to identify 27,110 CTCF binding sites from the Barski et al
maps [5], 17,328 of which are distal to promoters and predicted
enhancers. Applying ChromaSig to the chromatin modifications
around these loci, we recovered 7 clusters. The heat map
represents the enrichment of H2AZ, 20 histone modifications,
CTCF, and RNA polymerase II in the 10-kb region surrounding
each distal CTCF binding site. To organize these clusters visually,
we performed hierarchical clustering on the average profiles using
a Pearson correlation distance metric (left).
Found at: doi:10.1371/journal.pcbi.1000566.s005 (1.75 MB TIF)
Figure S6 Distinct chromatin signatures spanning Refseq 39
ends distal to Refseq promoters. Applying ChromaSig to the
histone modifications near 16,703 Refseq gene 39 ends that are
distal to Refseq TSSs, we recover 12 clusters. The heat map
represents the enrichment of H2AZ, 20 histone modifications,
CTCF, and RNA polymerase II in the 10-kb region surrounding
each Refseq gene 39 end. To organize these clusters visually, we
performed hierarchical clustering on the average profiles using a
Pearson correlation distance metric (left).
Found at: doi:10.1371/journal.pcbi.1000566.s006 (1.71 MB TIF)
Figure S7 Distinct chromatin signatures spanning DNase I
hypersensitive sites. Previously, Boyle et al mapped 95,709 DNase
I hypersensitive sites in CD4+ T cells, 31,824 of which are distal to
Refseq TSSs, CTCF binding sites, and enhancer predictions. We
applied ChromaSig to the chromatin modifications around these
loci, recovering 13 clusters. The heat map represents the
enrichment of H2AZ, 20 histone modifications, CTCF, and
RNA polymerase II in the 10-kb region surrounding each distal
DNase I hypersensitive site. To organize these clusters visually, we
performed hierarchical clustering on the average profiles using a
Pearson correlation distance metric (left).
Found at: doi:10.1371/journal.pcbi.1000566.s007 (3.28 MB TIF)
Figure S8 Chromatin signatures of distal regulatory elements
correlate with different classes of promoters. We partitioned the
genome into CTCF-defined domains and counted the number of
predicted enhancers and DNase I hypersensitive sites in each
promoter-containing domain. To calculate enrichment, we
compared to distributions of 100 sets of randomly placed loci
(see Methods).
Found at: doi:10.1371/journal.pcbi.1000566.s008 (0.72 MB TIF)
Figure S9 Distinct genomic distributions of chromatin signa-
tures. The percentage each cluster within the 59 and 39 ends of
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PLoS Computational Biology | www.ploscompbiol.org 13 November 2009 | Volume 5 | Issue 11 | e1000566genes (black), as compared to random sites (grey). The error bars
indicate 1 standard deviation.
Found at: doi:10.1371/journal.pcbi.1000566.s009 (0.19 MB TIF)
Figure S10 The distribution of H3K36me3 reads within exon
and introns. The number of reads found within introns and exons,
normalized by the total size of each.
Found at: doi:10.1371/journal.pcbi.1000566.s010 (0.04 MB TIF)
Figure S11 The distribution of H3K36me3 reads at long exon
59 and 39 ends. The top panel shows the enrichment of
H3K36me3 within 5-kb from (left) exon 59 ends and (right) 39
ends, for the longest 30,000 exons sorted by length (far right). The
bottom panel is the average H3K36me3 enrichment profile of the
shortest, middle, and longest third of exons from the top panel.
Found at: doi:10.1371/journal.pcbi.1000566.s011 (1.41 MB TIF)
Table S1 Locations of clusters recovered when applying
ChromaSig to Refseq promoters.
Found at: doi:10.1371/journal.pcbi.1000566.s012 (0.31 MB TXT)
Table S2 Locations of clusters recovered when applying
ChromaSig to predicted enhancers.
Found at: doi:10.1371/journal.pcbi.1000566.s013 (0.51 MB TXT)
Table S3 Locations of clusters recovered when applying
ChromaSig to CTCF binding sites.
Found at: doi:10.1371/journal.pcbi.1000566.s014 (0.27 MB TXT)
Table S4 Locations of clusters recovered when applying
ChromaSig to Refseq gene 39 ends.
Found at: doi:10.1371/journal.pcbi.1000566.s015 (0.25 MB TXT)
Table S5 Locations of clusters recovered when applying
ChromaSig to DNase I hypersensitive sites.
Found at: doi:10.1371/journal.pcbi.1000566.s016 (0.48 MB TXT)
Table S6 Locations of clusters recovered when applying
ChromaSig to ChIP-enriched sites distal to Refseq promoters,
Refseq gene 39 ends, predicted enhancers, CTCF binding sites,
and DNase I hypersensitive sites.
Found at: doi:10.1371/journal.pcbi.1000566.s017 (0.80 MB TXT)
Table S7 Statistical significance of observed chromatin signa-
tures. Significance for each cluster is calculated by comparing to
random sets of clusters sampled from within the cluster or over all
clusters.
Found at: doi:10.1371/journal.pcbi.1000566.s018 (0.30 MB PDF)
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